This assumes significance on the backdrop of two recent incidents...
Category:
Health
Latest
India reports 4, 435 coronavirus cases in 24 hours, highest in past six months
In the wake of rising COVID-19 cases in India, Union Health...
NHAI to provide hospitalisation insurance cover to road accident victims on all four arms of the Golden Quadrilateral stretch: Gadkari
Road Transport and Highways Minister Nitin Gadkari Replying to a...
Maha mulls suspension of trains, flights from Delhi amid Covid-19 surge
Various measures are being discussed in order to curb the virus spread in the state, and suspension of train and flight operations to and from Delhi is one of them,” principal secretary Sanjay Kumar told PTI. “However, no final decision has been taken so far,” he added.
Childhood vaccine may help prevent severe COVID-19
New Microsoft programme to nurture health tech startups in India
“Our partnership with Microsoft for HealthTech startups will focus on enabling these companies to fast track their progress with some of the best technology resources and accelerate their innovation pathways.”.
COVID-19 caseload in India breaches 90-lakh mark
The COVID-19 case fatality rate has further declined to 1.46 per cent.There are 4,43,794 active cases of coronavirus infection in the country which comprises 4.92 per cent of the total caseload, the data stated
According to the ICMR, a cumulative total of 12,95,91,786 samples have been tested up to November 20 with 10,83,397 samples being tested on Thursday
Questionable testing may be the reason India’s Covid-19 numbers are down
The result is that India’s Covid-19 cases are likely much higher than the national numbers. Health experts fear new infection waves as the country gathers to celebrate a season of weddings and Hindu festivals amid a smoggy winter in the densely populated north.
India could get access to AstraZeneca vaccine by January, local manufacturer says
The vaccine would be priced between $5-$6 in the retail market, but the Indian government would get it for much less, because they would buy it bulk, Adar Poonawaala, the chief executive of the SIIs aid.
Govt releases backend code of Aarogya Setu to enhance transparency
“Releasing backend code will help people in understanding the complete functioning of the app. This will clear any doubt that they have regarding privacy and security of their data,” a MeitY official explained.
EU could give conditional nod to Moderna vaccine as early as December
The EU could pay more than $10 billion to buy hundreds of millions of doses of the vaccine jointly developed by Pfizer Inc. and BioNTech as well as that of CureVac NV, Reuters said Friday, citing an EU official it didn’t name. The price it agreed for the Pfizer-BioNTech shot is 15.50 euros ($18.34) per dose, less than what the U.S. is paying, the newswire said.
Wealthy countries block COVID-19 drugs rights waiver at WTO – sources
Supporters of the waiver say existing intellectual property (IP) rules create barriers on access to affordable medicines and vaccines and they want restrictions to be eased, as they were during the AIDS epidemic.
Johnson & Johnson ordered to pay $120 million damages in New York baby powder case
Johnson & Johnson said it will appeal the verdict, citing “significant legal and evidentiary errors” at the trial.
“We deeply sympathize with anyone suffering from cancer, which is why the facts are so important,” the company said. “We remain confident that our talc is safe, asbestos free, and does not cause cancer.”